Shafique Virani, Global Head at Roche to speak at CNS Partnering meeting Sept 13-14, San Francisco

Top Quote Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche will give a featured presentation on the "Role of Business Development in Building and Enabling a World Class CNS Portfolio" at the 5th CNS Partnering and Deal-making Conference to be held in San Francisco, CA on September 13-14, 2012. End Quote
  • San Francisco, CA (1888PressRelease) July 27, 2012 - Dr. Virani's responsibilities encompass all partnering activities within Roche's neuroscience franchise from academic collaborations to licensing and acquisitions. He joined Roche in 2004 and served various roles within medical affairs and business development in the UK and USA until 2010, when he transitioned into his current role based in Basel, Switzerland. Dr. Virani trained as a neurosurgeon in Cambridge, UK and Boston, USA and holds the Fellowship of the Royal College of Surgeons of England.

    The 5th CNS Partnering and Deal-making is a CNS Diseases partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry. This event also provides a unique venue for attendees to learn about CNS Diseases business development trends, the CNS disease market, and novel technologies that shape up the industry.

    The conference is part of the CNS Diseases World Summit, which consists of 4 parallel tracks:
    1) 6th Neurodegenerative Conditions Research and Development
    2) 5th CNS Partnering and Deal-making
    3) 2nd Neuropsychiatric Research and Development
    4) Pain Research and Therapeutics

    For more information, please visit

  • FB Icon Twitter Icon In-Icon
Contact Information